Cargando…

Developments in renal pharmacogenomics and applications in chronic kidney disease

Chronic kidney disease (CKD) has shown an increasing prevalence in the last century. CKD encompasses a poor prognosis related to a remarkable number of comorbidities, and many patients suffer from this disease progression. Once the factors linked with CKD evolution are distinguished, it will be poss...

Descripción completa

Detalles Bibliográficos
Autores principales:	Padullés, Ariadna, Rama, Inés, Llaudó, Inés, Lloberas, Núria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157401/ https://www.ncbi.nlm.nih.gov/pubmed/25206311 http://dx.doi.org/10.2147/PGPM.S52763

Ejemplares similares

Impact of Olive Oil Supplement Intake on Dendritic Cell Maturation after Strenuous Physical Exercise: A Preliminary Study
por: Esquius, Laura, et al.
Publicado: (2021)

Online Haemodiafiltration Improves Inflammatory State in Dialysis Patients: A Longitudinal Study
por: Rama, Ines, et al.
Publicado: (2016)

Final Stage of Chronic Kidney Disease with Conservative Kidney Management or Renal Replacement Therapy: A Primary-Care Population Study
por: Bundó, Daniel, et al.
Publicado: (2023)

Effects of body weight variation in obese kidney recipients: a retrospective cohort study
por: Montero, Nuria, et al.
Publicado: (2019)

Pharmacogenomic Biomarkers and Their Applications in Psychiatry
por: Kam, Heejin, et al.
Publicado: (2020)

Clinical Application and Educational Training for Pharmacogenomics
por: Guy, Jason W., et al.
Publicado: (2020)

Genomics and Pharmacogenomics of Salt-sensitive Hypertension
por: Armando, Ines, et al.
Publicado: (2015)

Pharmacogenetics, pharmacogenomics and airway disease
por: Hall, Ian P
Publicado: (2002)

Role of pharmacogenomics in drug discovery and development
por: Surendiran, A., et al.
Publicado: (2008)

Strategies to Improve the Clinical Outcomes for Direct-to-Consumer Pharmacogenomic Tests
por: Tafazoli, Alireza, et al.
Publicado: (2021)

Mitochondrial DNA-Mediated Inflammation in Acute Kidney Injury and Chronic Kidney Disease
por: Jin, Lini, et al.
Publicado: (2021)

Pharmacogenomics of Antibiotics
por: Stocco, Gabriele, et al.
Publicado: (2020)

Pharmacogenomic application of the haptoglobin genotype in the treatment of HDL dysfunction
por: Schwartz, Avery, et al.
Publicado: (2009)

Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics
por: Beitelshees, Amber L, et al.
Publicado: (2015)

Pharmacometabolomics-aided Pharmacogenomics in Autoimmune Disease
por: Katsila, Theodora, et al.
Publicado: (2016)

Parkinson’s Disease: From Pathogenesis to Pharmacogenomics
por: Cacabelos, Ramón
Publicado: (2017)

Pharmacogenomics of Old and New Immunosuppressive Drugs for Precision Medicine in Kidney Transplantation
por: Turolo, Stefano, et al.
Publicado: (2023)

Emerging strategies and applications of pharmacogenomics
por: Milos, Patrice M, et al.
Publicado: (2004)

Opportunities and challenges of implementing Pharmacogenomics in cancer drug development
por: Tarantino, Paolo, et al.
Publicado: (2019)

Clinical application of high throughput molecular screening techniques for pharmacogenomics
por: Wiita, Arun P, et al.
Publicado: (2011)

Use of pharmacogenomics in pediatric renal transplant recipients
por: Medeiros, Mara, et al.
Publicado: (2015)

Pharmacogenomics of Hypertension Treatment
por: Rysz, Jacek, et al.
Publicado: (2020)

African Pharmacogenomics Consortium: Consolidating pharmacogenomics knowledge, capacity development and translation in Africa: Consolidating pharmacogenomics knowledge, capacity development and translation in Africa
por: Dandara, Collet, et al.
Publicado: (2019)

Recent Developments in Epigenetics of Acute and Chronic Kidney Diseases
por: Reddy, Marpadga A., et al.
Publicado: (2015)

Pharmacogenomics and Morphine
por: Ofoegbu, Adaku, et al.
Publicado: (2021)

Maternal and fetal outcomes of pregnancy in chronic kidney disease: diagnostic challenges, surveillance and treatment throughout the spectrum of kidney disease
por: Gouveia, Inês Filipe, et al.
Publicado: (2021)

Lipoprotein Abnormalities in Chronic Kidney Disease and Renal Transplantation
por: Barbagallo, Carlo Maria, et al.
Publicado: (2021)

Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine
por: Bochud, Murielle, et al.
Publicado: (2011)

Bucindolol: A Pharmacogenomic Perspective on Its Use in Chronic Heart Failure
por: Smart, Neil A., et al.
Publicado: (2011)

Pharmacogenomics of chronic hepatitis C therapy with genome-wide association studies
por: Wang, Chun-Hsiang, et al.
Publicado: (2010)

Pharmacogenomics of Viral Diseases
por: Dwivedi, Shailendra, et al.
Publicado: (2013)

Adding pharmacogenomics to the development of new marine-derived anticancer agents
por: Jimeno, José, et al.
Publicado: (2006)

Pharmacogenomics in Children: Advantages and Challenges of Next Generation Sequencing Applications
por: Vanakker, O. M., et al.
Publicado: (2013)

Precision Psychiatry Applications with Pharmacogenomics: Artificial Intelligence and Machine Learning Approaches
por: Lin, Eugene, et al.
Publicado: (2020)

PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease
por: Cresci, Sharon
Publicado: (2008)

Disease burden and the role of pharmacogenomics in African populations
por: Mpye, K. L., et al.
Publicado: (2017)

Pharmacogenomics: methods and protocols
por: Lai, C
Publicado: (2006)

Pharmacogenomics of pediatric asthma
por: Gupta, Sarika, et al.
Publicado: (2010)

Web Resources for Pharmacogenomics
por: Zhang, Guoqing, et al.
Publicado: (2015)

Applying Pharmacogenomics in Therapeutics
por: Jimenez-Sainz, Judit
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4vuis7hqu98a317j0elbmtjp7e